FINWIRES · TerminalLIVE
FINWIRES

Akamai Technologies Expected to Deliver Q1 Top-Line Beat, Oppenheimer Says

By

Akamai Technologies (AKAM) is expected to deliver a Q1 top-line beat, with revenue at the high end of guidance, led by average contract size rising by mid-single digits year over year, Oppenheimer said Thursday.

The larger contracts are driven by increased adoption of Guardicore and Noname security modules and cloud infrastructure capabilities. Oppenheimer expects Guardicore uptake to grow at least 25% and Noname 65% in 2026, driving at least 10% growth for the security portfolio.

The agentic web offers a notable opportunity for Akamai. The company's API security is considered "best in class" and gives it an edge in multi-content delivery network environments. Separately, both delivery and compute should benefit from the proliferation of agents, according to the note.

Given underlying business strength, recent price hikes, and a potential second-half agentic AI boost, Akamai can easily achieve the high end of its full-year revenue guide of 8%, and accelerate to 9%-to-10% growth by Q4, the investment firm said.

The company is set to report Q1 results on May 7.

Oppenheimer maintained an outperform rating on Akamai and raised the price target to $130 from $115.

Price: $95.48, Change: $-1.63, Percent Change: -1.68%

Related Articles

Wire

New Hope Completes AU$300 Million Convertible Notes Offering

New Hope (ASX:NHC) completed a AU$300 million issuance of 2.625% senior unsecured convertible notes due 2032 and the concurrent repurchase of AU$293.3 million of its existing 2029 convertible notes, according to a Thursday filing with the Australian bourse.The new notes are expected to be listed on the Singapore Exchange Securities Trading on or around Thursday, per the filing.The repurchased 2029 notes, which account for around 98% of the outstanding notes, will be cancelled under their terms, the filing said. The company also plans to redeem the remaining AU$6.7 million of notes at par plus accrued interest prior to maturity.

ASX:NHC
Wire

Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes

Telix Pharmaceuticals (ASX:TLX) said it settled the issue of $600 million in 1.50% convertible notes due 2031, according to a Thursday Australian bourse filing.The convertible notes are expected to be listed on the Official List of the Singapore Exchange Securities Trading on Thursday.In the same filing, the company said that the repurchase of around AU$637 million in principal of the AU$650 million worth of 2.375% convertible bonds due 2029 is "substantially complete."After the repurchase, given that less than 15% in aggregate principal amount of the existing bonds will remain outstanding, Telix said it plans to exercise its right to repurchase and cancel all of the remaining existing bonds at their principal amount.

ASX:TLX
Wire

Century Communities Q1 Adjusted Earnings, Revenue Fall

Century Communities (CCS) reported Q1 adjusted earnings late Wednesday of $0.88 per diluted share, down from $1.39 a year earlier.Three analysts polled by FactSet expected $0.59.Revenue for the three months ended March 31 fell to $789.7 million from $903.2 million a year earlier.Four analysts surveyed by FactSet expected $807.7 million.

$CCS